Company Filing History:
Years Active: 2003-2017
Title: The Innovative Contributions of Volkhard Lindner
Introduction
Volkhard Lindner, based in South Portland, ME, has made significant advancements in the fields of medicine and biotechnology. With three patents to his name, Lindner's innovative work primarily focuses on cardiac health and metabolic syndrome, showcasing his commitment to developing treatments that can greatly improve patient outcomes.
Latest Patents
Lindner's latest inventions include a kit for detecting Cthrc1 in a sample. This invention features methods for treating coronary heart disease, peripheral vascular disease, stroke, and ischemia through agents that interfere with the expression or activity of Cthrc1. Additionally, it provides the use of Cthrc1 peptide as a therapeutic agent for treating acute or chronic cardiac deficiencies, along with methods for detecting and monitoring Cthrc1 peptide levels in blood or serum to assess cardiac function.
Another notable patent from Lindner involves methods for treating metabolic syndrome using Cthrc1 polypeptide. This invention focuses on compositions and methods aimed at preventing metabolic syndrome through the collagen triple helix repeat containing-1 (Cthrc1) protein, highlighting his innovative approach to tackling pressing health issues.
Career Highlights
Throughout his career, Volkhard Lindner has contributed to significant research and development at esteemed institutions. He has been associated with the Maine Medical Center and the Maine Medical Center Research Institute, where his research has paved the way for groundbreaking treatments in his areas of expertise.
Collaborations
Lindner has had the privilege of collaborating with talented coworkers like Robert E. Friesel and Ilka Pinz. Their combined efforts have undoubtedly enhanced the research outcomes and led to the successful development of innovative medical solutions.
Conclusion
Volkhard Lindner’s contributions to the field of healthcare through his patents demonstrate the power of innovation in addressing critical health concerns. His work continues to inspire future inventions that hold the promise of improving the quality of life for patients dealing with cardiac issues and metabolic syndrome.